Brief: Kolinpharma Gets Patent In U.S. For Ivuxur Product
17/06/2019 16:34
June 17 (Reuters) - Kolinpharma SpA KIP.MI :
* GETS PATENT IN U.S. FOR THE IVUXUR PRODUCT
* PATENT WILL BE VALID UNTIL MAY 2036
Source text for Eikon: ID:nBIA6twPHk
Further company coverage: KIP.MI
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Kolinpharma SpA
See all newsBrief: Igea Holding Crosses 95% Of Kolinpharma In Context Of Takeover Bid
Brief: Kolinpharma Shareholder PRP Sells About 59.62% Of Share Capital To Igea Holding
Brief: Igea Holding Buys Additional 0.927% Of Kolinpharma Share Capital
Brief: Takeup In Takeover Bid By Igea Holding On Kolinpharma Reaches 59.411% Of Shares To Which Offer Relates
Brief: Igea Holding Buys 4.9% Of Kolinpharma Share Capital, Surpasses 90% Treshold